Comparison of efficacy and safety of injectable iron sucrose with oral ferrous ascorbate in the treatment of anaemia in pregnancy


  • Sunitha H. B. Department of Obstetrics and Gynecology, Gadag Institute of Medical Sciences, Gadag, Karnataka, India
  • Sunil Kumar G. S. Consultant, Nandini Hospital, Davangere, Karnataka, India



Anaemia, Iron sucrose, Ferrous ascorbate, Pregnancy


Background: Anemia due to Iron deficiency is the commonest malnutrition disorder seen throughout the world and in India. It is also responsible for increased incidence of premature births, low birth weight babies and high perinatal mortality. Hence, the present study undertaken to assess efficacy and safety of injectable iron sucrose with oral ferrous ascorbate.

Methods: 100 pregnant women, between gestational age 14 and 28 weeks were divided randomly into two groups i.e. group A consists of oral iron, a total of 200 mg of elemental iron per day, two 100mg iron tablets per day and group B consists of iron sucrose at the rate of 200mg on alternate OPD day. Informed consent was taken from each patient.

Results: The percentage rise in hemoglobin at fourth and eighth weeks of treatment was statistically significant when compared to the baseline. Statistically significant rise in hemoglobin, PCV and ferritin levels were found at fourth and eighth weeks in IV group when compared to oral group.

Conclusions: This study concluded that intravenous iron sucrose is safe and highly efficacious for the treatment of anemia in pregnancy. It restores iron stores more promptly. Iron sucrose therapy is more effective in achieving the optimum results, an increase in hemoglobin concentration, PCV levels and an increase in ferritin levels also. Therefore, it is a suitable alternative to oral iron with minimal side effects in those patients who cannot tolerate oral iron therapy.



World Health Organization. Nutritional anaemias: report of a WHO scientific group [meeting held in Geneva from 13 to 17 March 1967].

WHO U. UNU. Iron deficiency anaemia: assessment, prevention, and control. Geneva, WHO. 2001.

WHO, The prevalence of anemia in women: A tabulation of available information, WHO/MCH/MSM/92.2 World Health Organization, 1992.

Centers for Disease Control and Prevention. Recommendations to prevent and control iron deficiency in the United States. MMWR Recomm Rep. 1998;47(RR-3):1-29.

Vijayaraghavan K, Brahmam GN, Nair KM, Akbar D, Rao NP. Indian council of medical research. Task force study Evaluation of national nutritional anemia prophylaxis programme. Indian J Pediatr. 1990;57(2):183-90.

Singh K, Fong YF, Kuperan P. A comparison between intravenous iron polymaltose complex (Ferrum Hausmann) and oral ferrous fumarate in the treatment of iron deficiency anemia in pregnancy. Eur J Haematol. 1998;60(2):119-24.

Ragip A, Intravenous versus oral iron for treatment of anemia in pregnancy, A randomized trial, ACOG. 2005;106(6):1335-40.

Bayoumeu F, Subiran-Buisset C, Baka NE, Legagneur H, Monnier-Barbarino P, Laxenaire MC. Iron therapy in iron deficiency anemia in pregnancy: intravenous route versus oral route. European Journal of Obstet Gynecol Reproduct Biol. 2005;123:S15-9.

Dede A, Uygur D, Yilmaz B, Mungan T, Uğur M. Intravenous iron sucrose complex vs. oral ferrous sulfate for postpartum iron deficiency anemia. Int J Gynecol Obstet. 2005;90(3):238-9.

Al-Momen AK, Al-Meshari A, Al-Nuaim L, Saddique A, Abotalib Z, Khashogji T, Abbas M. Intravenous iron sucrose complex in the treatment of iron deficiency anemia during pregnancy. European Journal of Obstet Gynecol Reproduct Biol. 1996;69(2):121-4.

Shafi D, Purandare SV, Sathe AV. Iron deficiency anemia in pregnancy: intravenous versus oral route. J Obstet Gynecol India. 2012;62(3):317-21.






Original Research Articles